Thermo Fisher Scientific has entered into a strategic data collaboration with Datavant aimed at expanding real-world data (RWD) interoperability and linkage across clinical research and development ...

With its stock down 18% over the past month, it is easy to disregard Thermo Fisher Scientific (NYSE:TMO). However, ...

Thermo Fisher Scientific has introduced a laboratory kit designed to extract protein, DNA and RNA from a single biological ...

The biotech-giant announced plans to lay off 300 employees last year. Now, it's eliminating 8- more positions and closing a ...

On CNBC's “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital ...

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% ...

Thermo Fisher Scientific and Datavant are facilitating connection of real-world data with clinical research for pharma and biotech.

Thermo Fisher Scientific provides products and services that support the life sciences industry, including large pharmaceutical companies, biotechnology firms, government agencies and academic ...

Thermo Fisher Scientific Korea has renewed its partnership with a state-funded chemical research agency to cooperate on the ...

Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier ...

I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact innovations ...

Third quarter revenue grew 5% to $11.12 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter. Third quarter adjusted EPS grew 10% to $5.79.